Abstract:Background: The evaluation and interpretation of the results from blood tests measuring specific immunoglobulin E (IgE) antibody concentration is currently made using the dichotomized result from the test despite a quantitative result is obtained. It has been shown that different levels of IgE antibodies, assessed by blood test and skin prick test, may have a relation to presence of symptoms, implying that there is more information in a quantitative result than in the dichotomous--positive or negative. Objective: To investigate the clinical utility of quantification of IgE antibodies in the diagnosis of allergic patients and whether such procedure has any advantage to the presently dichotomously used sensitivity and specificity at a fixed cut-off. Methods: Data from a previously published study (R. Paganelli, I.J. Ansoteugi, J. Sastre, C.-E. Lange, M.H.W.M. Roovers, H. de Groot, N.B. Lindholm, P.W. Ewan, Allergy, 1998; 53) analysing diagnosis of allergic patients in four different clinics were re-evaluated. In the original study consecutive patients with suspected IgE-mediated allergy had been examined and evaluated according to the clinical routine at each clinic, using case history, physical examination, skin tests and laboratory tests, except the test to be evaluated, and given a "doctors' allergen-specific diagnosis" as positive or negative. In the present study the relation between "doctors' allergen-specific diagnosis", expressed as pos/neg, and the quantitative levels of specific IgE antibody concentration was analysed using a logistic regression model. This presentation of results was also compared with the more common characteristics of sensitivity and specificity, and also with Receiver-operator characteristics (ROC) curves. Results: The used logistic model described the relationship between allergen-specific diagnosis in each study and the levels of IgE antibodies. The shape of the curve illustrated the physicians' disposition for a positive diagnose in the study, in relation to the specific IgE antibody level. Differences in the shape of the curve was found both between allergens within clinics and between clinics for the same allergen. No association could be demonstrated between prevalence and shape of the curve. Conclusions: Conventional sensitivity/specificity figures or ROC concepts only use the qualitative statement of whether IgE is present or not. A risk assessment using the quantitative level of IgE antibody to an allergen increases the utility of the information in clinical context compared with a qualitative statement of whether IgE is present or not. The quantification demonstrated the link between specific IgE antibodies and allergic reactions. The use of objective, well performing quantitative tests should help improve diagnostic accuracy and might provide a way for the patient to understand and manage his or her daily situation and risk for reactions.

Clinical study on the utility of allergy tests to detect IgE-mediated anaphylaxis after diclofenac etalhyaluronate administration

Consideration of the EXiLE test for predicting anaphylaxis after diclofenac etalhyaluronate administration

Potential Therapeutic Hazards Due to Drug–drug Interaction Between Topically and Systemically Coadministered Medications

Evaluation of the Role of IgE Responses to Der f 1 and Der f 2 in House Dust Mite-allergic Patients

Effects of Diclofenac Etalhyaluronate (SI-613/ONO-5704) on Cartilage Degeneration in Arthritic Rats and Inflammatory Cytokine-Stimulated Human Chondrocytes

Molecular characterization of allergens and component-resolved diagnosis of IgE-mediated mango fruit allergy

Different patterns of response in hypersensitivity reactions to arylpropionic acid derivatives.

Identification of Potential Allergens of Atractylodes japonica and Addition of Panels for Allergic Diseases

JACQLQ subjective symptom questionnaire score and clinical test results for patients with allergic conjunctival disease

Open-label phase 3 study of diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate: ONO-5704/SI-613) for treatment of osteoarthritis: 1-year follow-up

Diagnostic procedures & practices in drug allergy/hypersensitivity: a survey of 13 Asian countries

SMALL DOSE DICLOFENAC DELIVERED IN HYALURONAN RELIEVES ORAL APHTHOUS ULCER PAIN—— A RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL

Linking cross-reactivity clusters of food and respiratory allergens in PAMD@ to asthma and duration of allergy

Clinical assessment of 0.1% Diclofenac Sodium eye drops on the treatment of acute allergic conjunctivitis

Diclofenac-Induced Allergic Contact Dermatitis: A Series of Four Patients

Effects and potential mechanisms of Saposhnikovia divaricata (Turcz.) Schischk. On type I allergy and pseudoallergic reactions in vitro and in vivo

Qualitative and quantitative analysis of Arnebiae Radix and Dictamni Cortex and efficacy study of herbal extracts on allergic contact dermatitis using 3D human reconstructed epidermis

Investigation of the sensitization rate for gibberellin-regulated protein in patients with Japanese cedar pollinosis

Safety of subcutaneous immunotherapy with Novo-Helisen-Depot in the children: a retrospective analysis from a single center in Northern China

Dust mite component Analysis: Identifying key allergens components for effective immunotherapy in allergic rhinitis

A further evaluation of the clinical use of specific IgE antibody testing in allergic diseases